FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis

Aurinia Pharmaceuticals Inc. (AUPH)
Published on :

FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis – LUPKYNIS is the first FDA-approved oral therapy for lupus nephritis (LN), a condition that causes irreversible [….]